utilized claims records extracted from the National Health Insurance Research Database (NHIRD) and suggested that patients with diabetes who underwent GLP-1 RA therapy experienced a significant reduction in the risk of anxiety 20
A scoping review of GLP-1 receptor agonists: Are they associated with increased gastric contents, regurgitation, and aspiration events
Ultimately, microdosing sounds appealing, but its results arent guaranteed or backed by much evidence
The fix: find non-food, non-alcohol social activities
Sharing this genetic snapshot with your provider can support a more informed conversation about which GLP-1 formulation and dosing strategy might align with your biology
The media frenzy over these so-called "weight loss drugs" has also resulted in pharmaceutical companies tightening restrictions on who is able to access the medications, leading to rejections of valid prescriptions, delays in treatment, and other issues